共 50 条
- [1] A randomized controlled clinical trial to compare the efficacy of LY333334 [recombinant human parathyroid hormone (1-34)] and alendronate sodium in postmenopausal women with osteoporosis.JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S179 - S179Body, JJGaich, GAScheele, WHMiller, PDKulkarni, PMHodsman, AB
- [2] Incident vertebral fractures during an 18-month observation period following discontinuation of LY333334 [recombinant human parathyroid hormone (1-34), rhPTH(1-34)] use in postmenopausal women with osteoporosis.JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S162 - S162Lindsay, RScheele, WHClancy, ADMitlak, BH
- [3] Lumbar spine bone mineral density response rates in a study of recombinant human parathyroid hormone (1-34) compared to alendronate sodium in postmenopausal women with osteoporosis.ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S379 - S379Kulkarni, PMGaich, GAScheele, WH
- [4] Daily treatment with human recombinant parathyroid hormone-(1-34), LY333334, for 1 year increases bone mass in ovariectomized monkeysJOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (10): : 3757 - 3763Brommage, RHotchkiss, CELees, CJStancill, MWHock, JMJerome, CP
- [5] Effects of teriparatide [recombinant human parathyroid hormone (1-34)] on cortical bone in postmenopausal women with osteoporosisJOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 (03) : 539 - 543Zanchetta, JRBogado, CEFerretti, JLWang, OWilson, MGSato, MGaich, GADalsky, GPMyers, SL
- [6] Early effects of human parathyroid hormone (1-34), LY333334, on bone mass, remodeling and mechanical properties of cortical bone in rabbitsJOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 (04) : 804 - 804Mashiba, TBurr, DBTurner, CHSato, MCain, RLHock, JM
- [7] Changes in bone mineral density 18 months after cessation of recombinant human parathyroid hormone (1-34) or alendronate treatment in postmenopausal women with osteoporosis.ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S254 - S254Dore, RKHodsman, ABScheele, WHBody, JLMiller, PDClancy, ADMyers, SLGaich, GA
- [8] Assessment of effects of LY333334 [recombinant human parathyroid hormone (1-34)] on cortical bone using digital X-ray radiogrammetry.BONE, 2001, 28 (05) : S97 - S98Hyldstrup, LJorgensen, JTGaich, G
- [9] Comparison of dose, drug concentrations, and biochemical markers of bone turnover as predictors of bone mineral density response to LY333334 [rhPTH(1-34)] in women with osteoporosis.JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 : S230 - S230Satterwhite, JHMelnick, KAO'Brien, LMGaich, GAHeathman, MA
- [10] In vivo and in vitro comparison of LY333334, biosynthetic human parathyroid hormone (hPTH) (1-34), with synthetic hPTH(1-34).JOURNAL OF BONE AND MINERAL RESEARCH, 1997, 12 : F370 - F370Black, ECFrolik, CAHock, JMCain, RLChandrasekhar, SHarvey, AK